Medicinal Genomics

FEBRUARY 8, 2024

The subsequent investigation did not determine a definitive cause for the condition; however, the report did mention investigators tested the air for levels of endotoxin, “a pro-inflammatory contaminant associated with gram-negative bacterial growth on organic materials such as cannabis flower”.

Treatment 98

Treatment Dispensary Safety Cannabis 98

PrestoDoctor

MARCH 23, 2021

If you are considering medical marijuana for pain management, it’s essential to know which conditions it can ease. Continue reading as we list the top common pain conditions that medical marijuana is proven to help patients. Migraines and headaches can be debilitating and severe conditions. Migraines and Headaches.

Conditions 52

Conditions Marijuana Chronic Pain Strains 52

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Adverse events were mostly mild and resolved spontaneously.

Clinical Trials 243

Clinical Trials Chronic Pain Cannabinoids Patients 243

Cannabis Law Report

OCTOBER 15, 2021

(USOTC: PAOG) cited a British Medical Journal case study report published today on the effectiveness of CBD in the treatment of lung cancer and COPD as validation of PAOG’s ongoing research and development of its own respiratory disorder treatment under the name RespRx.

Treatment 52

Treatment Research and Development CBD Clinical Trials 52

NORML

JUNE 18, 2019

Eight-one percent of subjects reported “at least moderate improvement in their condition … without experiencing serious adverse events.” Israeli investigators assessed the use of cannabis over a six-month period in 211 patients with the disease.

Patients 279

Patients Therapy Data Safety 279

Cannabis Law Report

APRIL 19, 2023

Here’s the blurb With research showing that psychedelics hold substantial promise for the treatment of mental health conditions such as depression, PTSD and addiction, PSYCH Symposium provides a platform for decision makers to accelerate the development and delivery of these medicines.

Research and Development 52

Research and Development Events Treatment Policy 52

Cannabis Law Report

FEBRUARY 12, 2023

Event description Don’t miss out – Get your tickets early! Join this FREE, 75-minute online webinar to gain access to insights and learn about ground-breaking treatments to chronic mental health conditions.

Policy 52

Policy Medicine Events Treatment 52

Cannabis Law Report

DECEMBER 15, 2021

A number of clinical trials have been investigating the potential of psychedelics in mental health treatment. Following research findings here and abroad, the application sought to have the drugs used as part of psychotherapy treatment for mental illnesses, depression and post-traumatic stress disorder. ” [link].

Clinical Trials 52

Clinical Trials Conditions Supply Chain Environment 52

The Joint Blog

APRIL 17, 2020

But as an older user-base with more complicated medical conditions continue to grow, it is important to understand how THC could adversely impact other co-administered medications. Medical cannabis is typically prescribed for patients with severe conditions including inflammatory conditions (e.g.,

Events 48

Events THC Chronic Pain Sleep 48

Illinois News Joint

FEBRUARY 8, 2023

With a philosophy rooted in trauma-informed care, they believe in client-led healing and strive to truly listen and collaborate with patients to create individualized treatment plans that meet unique needs and lifestyles. We work with patients of all ages with a wide variety of conditions.

Patients 91

Patients Treatment Environment Conditions 91

MMJ Recs

DECEMBER 20, 2023

The establishment of medical marijuana dispensaries in Virginia represents a progressive approach to healthcare, offering patients alternative treatment options for various medical conditions. Patients diagnosed with specific medical conditions are eligible to participate in the state’s medical cannabis program.

Dispensary 52

Dispensary Marijuana Strains Patients 52

Cannabis Law Report

JULY 12, 2019

Rachel Levine today announced that effective July 20, anxiety disorders and Tourette syndrome will be approved serious medical conditions in the medical marijuana program based on the recommendation of the Medical Marijuana Advisory Board and a review of medical research on the use of marijuana to treat these conditions.

Conditions 40

Conditions Programs Research and Development Marijuana 40

Veriheal

AUGUST 21, 2023

The non-profit seeks to explore how psychedelics, such as MDMA , LSD, and psilocybin (the active ingredient in magic mushrooms), can be utilized in a controlled and supervised environment to treat various medical conditions like depression, anxiety, PTSD, and addiction.

Therapy 92

Therapy Research and Development Treatment Environment 92

Illinois News Joint

MAY 21, 2023

On the telehealth conference, we discussed my conditions and treatments I’ve already incorporated, along with other pertinent information that helped detail the best-suited care for my personal needs. To learn about cannabis-friendly events in Illinois, visit here. For more Illinois cannabis industry news, visit here.

Education 94

Education Patients Treatment Conditions 94

MMJ Recs

MARCH 30, 2022

PA MMJ dispensaries sell a wide range of medical marijuana products that treat the symptoms of a long list of qualifying medical conditions. Pennsylvania patient drives have helped thousands of people to avail of MMJ treatment in PA. Why are Pennsylvania patient drive events great for patients and dispensaries?

Patients 52

Patients Dispensary Events Treatment 52

Veriheal

JULY 12, 2021

According to the American Psychiatric Association , PTSD is a “psychiatric disorder that may occur in people who have experienced or witnessed a traumatic event such as natural disaster, as a serious accident, a terrorist act, war/combat or rape or who have been threatened with death, sexual violence or serious injury”.

Treatment 104

Treatment Sleep Clinical Trials Data 104

Veriheal

MARCH 18, 2021

They needed a model for Alzheimer’s disease in order to effectively review cannabidiol (CBD) as a potential treatment. Unfortunately, both of these conditions result in cognitive decline and suffer from a lack of effective treatment. Why Aging Cats? What Did The Study Find?

CBD 97

CBD Research and Development Pets Treatment 97

Illinois News Joint

SEPTEMBER 18, 2023

During my days as a budtender, medical patients with truly debilitating conditions often searched for a higher level of relief than most products provided. Progressive Treatment Solutions produces its own label of RSO called The Antidote, so I headed to Consume Marion and picked up a half-gram Chem 91 to review.

Oil 94

Oil Hybrid Food Treatment 94

Veriheal

MAY 30, 2023

But what if a safe and effective complementary plant-based treatment was widely available to alleviate cancer pain? of patients experience pain after curative treatment, while 66.4% in cancer patients undergoing anticancer treatment, 50.7% in those who had completed treatment, and as high as 66.7%

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. About Delic Corp, Inc.

Research and Development 98

Research and Development Treatment Media Medicine 98

CannaMD

FEBRUARY 19, 2020

Post-traumatic stress disorder (PTSD) is a condition most often associated with military veterans, but it is not confined to wartime experiences. Before getting to this news, let’s take a minute to review some of the prior research supporting marijuana for the treatment PTSD. How CBD Targets Fear-Related Memories.

CBD 92

CBD Pharmaceutical Research and Development Conditions 92

Cannabis Law Report

JUNE 16, 2021

Patients deserve more options, and to be assured of the safety and efficacy of their treatments; similarly, physicians deserve answers and are a critical partner in the development of this new therapeutic class,” says Erin Prosk , President of Santé. We are excited to explore the potential of emergent psychedelic therapies.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

AUGUST 2, 2021

capital markets, negative global economic conditions, potential negative developments in our clinical trials or research programs, other negative developments in our business, or unfavorable legislative or regulatory developments. Each ADS would represent a certain number of fully paid ordinary shares in Bionomics.

Clinical Trials 105

Clinical Trials Research and Development Treatment Conditions 105

The Cannigma

MAY 5, 2021

The condition, known as “long COVID” — with patients often referred to as “COVID long haulers” — is typified by a series of symptoms that linger long after someone has recovered from COVID-19, even months after they no longer test positive for the novel coronavirus. episodes per month. Depression and anxiety.

Chronic Pain 144

Chronic Pain Research and Development Patients Treatment 144

Cannabis Law Report

JANUARY 14, 2022

Any dollars collected from psychedelics possession violations would go to the state’s Drug Offender Assessment and Treatment Fund, which supports substance misuse treatment programs and drug courts. Dawn Adams (D) and Sen. Ghazala Hashmi (D) are sponsoring the nearly identical measures. Read more at. .

Decriminalization 52

Decriminalization Treatment Collective Events 52

TheAnswerPage

AUGUST 26, 2022

This question begins “The Answer of the Day” series on the treatment effects of cannabinoids…. Has it been shown that any cannabinoids have a significant therapeutic effect on a health condition? Efficacy, retention and the adverse events of medical cannabinoids were examined.

Cannabinoids 52

Cannabinoids Epilepsy Treatment Conditions 52

MMJ Recs

APRIL 10, 2022

Oklahoma patient drives have been making medical marijuana cards available to Oklahomans who have a range of debilitating conditions. Why are OK patient drive events great for patients and dispensaries? Why Are OK Patient Drive Events Great For Patients And Dispensaries? So, what are patient drives in Oklahoma? Let’s find out.

Patients 52

Patients Dispensary Events Conditions 52

Cannabis Law Report

SEPTEMBER 24, 2021

Even the most conservative states have allowed treatment of PTSD with cannabis. A recent sign of this change occurred when ultra-conservative Texas expanded the list of conditions the state allows marijuana to treat. They include anxiety, stress and processing the events that originally caused the trauma. What Is PTSD?

Marijuana 52

Marijuana Events Conditions Advocacy 52

Cannabis Law Report

JUNE 10, 2019

Change of legislation for medical cannabis is leading to an influx of patients across primary and secondary care enquiring about this treatment. Medical cannabis treatments: prescribing experiences and approaching difficult areas. Professor Mike Barnes, author and Director of Education at The Academy of Medical Cannabis.

Events 40

Events Research and Development History Education 40

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

MMJ Recs

DECEMBER 15, 2023

However, the scientific evidence supporting its efficacy for insomnia treatment is still limited, and the long-term effects and potential risks should be carefully considered. Medical Conditions: Various medical conditions, including chronic pain, respiratory disorders, and neurological issues, can contribute to insomnia.

Strains 98

Strains Sleep THC Indica 98

Veriheal

FEBRUARY 28, 2021

It helps to showcase the 103 countries holding events on this day as well as the thousands of events hosted online worldwide. This year, COVID-19 has dramatically impacted the way events are hosted. Instead of having physical locations, many events have opted to go digital being held online.

Chronic Pain 52

Chronic Pain Events Therapy Treatment 52

Cannabis Law Report

JULY 24, 2021

BetterLife’s goal is to bring this treatment to the Investigational New Drug (“IND”) application and the clinic as soon as possible because it is non-addictive yet potentially highly effective. TD-010 is a treatment of anxiety without the addictive potential of benzodiazepines. Benzodiazepine Dependency. neuroscience. About Mitacs.

Research and Development 98

Research and Development Treatment Therapy Media 98

Cannabis Law Report

DECEMBER 9, 2021

At a virtual event organized by the reform group Decriminalize Nature Virginia, Sen. Dawn Adams (D) participated as hosts, sharing their perspectives about the growing body of research indicating that psychedelics could be powerful tools to combat conditions like treatment-resistant depression and post-traumatic stress disorder (PTSD).

Decriminalization 52

Decriminalization Medicine Events Treatment 52

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Patients must first schedule an appointment with a licensed medical professional who can evaluate their medical history and condition.

Dispensary 52

Dispensary Patients Environment Conditions 52

Cannabis Law Report

JUNE 23, 2021

. “We are excited to be initiating our pilot program with Medicann in Jersey, which represents a unique, ‘ring-fenced’ environment for establishing potentially numerous studies on the efficacy of treatments using plant-based therapies.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

OCTOBER 14, 2021

The current state of mental health globally, existing treatments and the need for innovation. International Keynotes: Professor David Nutt (UK) – The neuroscience of new treatments. Dr Ben Sessa (UK) – MDMA-Assisted Psychotherapy for the Treatment of Alcohol Use Disorder: The results of the BIMA trial. Session 7.

Therapy 105

Therapy Medicine Treatment Programs 105